Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-01-10 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2019-01-11 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-02-01 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2017-05-17 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-05-24 Richards Christos Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2015-11-13 Richards Christos Director Sale −7,988 $27.38 $219K 67,848
2015-11-13 Richards Christos Director Sale −4,012 $27.93 $112K 63,836
2015-11-12 Richards Christos Director Sale −3,000 $27.23 $82K 75,836
2015-04-01 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2015-04-01 Richards Christos Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2014-11-12 Richards Christos Director Option exercise +26,505 $1.67 $44K 26,505
2014-11-12 Richards Christos Director Other disposition −2,956 23,549
2014-11-12 Richards Christos Director Conversion +39,991 63,540
2014-11-12 Richards Christos Director Conversion +12,672 76,212
2014-11-12 Richards Christos Director Conversion +2,624 78,836
2014-11-12 Richards Christos Director Option exercise · Warrant to Purchase Common Stock −26,505 0
2014-11-12 Richards Christos Director Option exercise · Warrant to Purchase Series B Preferred Stock −429 0
2014-11-12 Richards Christos Director Option exercise · Series B Preferred Stock +429 $0.02 $7 12,673
2014-11-12 Richards Christos Director Other disposition · Series B Preferred Stock −1 12,672
2014-11-12 Richards Christos Director Conversion · Series A Preferred Stock −39,991 0

Page 1 of 2 · 22 trades